221 related articles for article (PubMed ID: 31893043)
1. Cysteine catabolism and the serine biosynthesis pathway support pyruvate production during pyruvate kinase knockdown in pancreatic cancer cells.
Yu L; Teoh ST; Ensink E; Ogrodzinski MP; Yang C; Vazquez AI; Lunt SY
Cancer Metab; 2019; 7():13. PubMed ID: 31893043
[TBL] [Abstract][Full Text] [Related]
2. Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.
Méndez-Lucas A; Li X; Hu J; Che L; Song X; Jia J; Wang J; Xie C; Driscoll PC; Tschaharganeh DF; Calvisi DF; Yuneva M; Chen X
Cancer Res; 2017 Aug; 77(16):4355-4364. PubMed ID: 28630053
[TBL] [Abstract][Full Text] [Related]
3. Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein.
Cheng TY; Yang YC; Wang HP; Tien YW; Shun CT; Huang HY; Hsiao M; Hua KT
Oncogene; 2018 Mar; 37(13):1730-1742. PubMed ID: 29335522
[TBL] [Abstract][Full Text] [Related]
4. Pyruvate Kinase Activity Regulates Cystine Starvation Induced Ferroptosis through Malic Enzyme 1 in Pancreatic Cancer Cells.
Ensink E; Jordan T; Medeiros HCD; Thurston G; Pardal A; Yu L; Lunt SY
bioRxiv; 2023 Sep; ():. PubMed ID: 37745559
[TBL] [Abstract][Full Text] [Related]
5. The cysteine residue at 424th of pyruvate kinase M2 is crucial for tetramerization and responsiveness to oxidative stress.
Masaki S; Hashimoto K; Kihara D; Tsuzuki C; Kataoka N; Suzuki K
Biochem Biophys Res Commun; 2020 Jun; 526(4):973-977. PubMed ID: 32295714
[TBL] [Abstract][Full Text] [Related]
6. PKM2 is not required for pancreatic ductal adenocarcinoma.
Hillis AL; Lau AN; Devoe CX; Dayton TL; Danai LV; Di Vizio D; Vander Heiden MG
Cancer Metab; 2018; 6():17. PubMed ID: 30386596
[TBL] [Abstract][Full Text] [Related]
7. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.
Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K
Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate kinase M1 regulates butyrate metabolism in cancerous colonocytes.
Park B; Kim JY; Riffey OF; Dowker-Key P; Bruckbauer A; McLoughlin J; Bettaieb A; Donohoe DR
Sci Rep; 2022 May; 12(1):8771. PubMed ID: 35610475
[TBL] [Abstract][Full Text] [Related]
9. Preventing pyruvate kinase muscle expression in Chinese hamster ovary cells curbs lactogenic behavior by altering glycolysis, gating pyruvate generation, and increasing pyruvate flux into the TCA cycle.
Tang D; Sandoval W; Liu P; Lam C; Snedecor B; Misaghi S
Biotechnol Prog; 2021 Sep; 37(5):e3193. PubMed ID: 34288605
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
Prakasam G; Singh RK; Iqbal MA; Saini SK; Tiku AB; Bamezai RNK
J Biol Chem; 2017 Sep; 292(37):15561-15576. PubMed ID: 28778925
[TBL] [Abstract][Full Text] [Related]
11. Isoform switch of pyruvate kinase M1 indeed occurs but not to pyruvate kinase M2 in human tumorigenesis.
Zhan C; Yan L; Wang L; Ma J; Jiang W; Zhang Y; Shi Y; Wang Q
PLoS One; 2015; 10(3):e0118663. PubMed ID: 25738776
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.
Zhang H; Wang D; Li M; Plecitá-Hlavatá L; D'Alessandro A; Tauber J; Riddle S; Kumar S; Flockton A; McKeon BA; Frid MG; Reisz JA; Caruso P; El Kasmi KC; Ježek P; Morrell NW; Hu CJ; Stenmark KR
Circulation; 2017 Dec; 136(25):2468-2485. PubMed ID: 28972001
[TBL] [Abstract][Full Text] [Related]
13. Pyruvate kinase M1 interacts with A-Raf and inhibits endoplasmic reticulum stress-induced apoptosis by activating MEK1/ERK pathway in mouse insulinoma cells.
Horiuchi Y; Nakatsu D; Kano F; Murata M
Cell Signal; 2017 Oct; 38():212-222. PubMed ID: 28743549
[TBL] [Abstract][Full Text] [Related]
14.
Kimura A; Kitamura K; Ailiken G; Satoh M; Minamoto T; Tanaka N; Nomura F; Matsushita K
Oncotarget; 2017 Sep; 8(40):67955-67965. PubMed ID: 28978087
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth.
Chiavarina B; Whitaker-Menezes D; Martinez-Outschoorn UE; Witkiewicz AK; Birbe R; Howell A; Pestell RG; Smith J; Daniel R; Sotgia F; Lisanti MP
Cancer Biol Ther; 2011 Dec; 12(12):1101-13. PubMed ID: 22236875
[TBL] [Abstract][Full Text] [Related]
16. PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth.
Morita M; Sato T; Nomura M; Sakamoto Y; Inoue Y; Tanaka R; Ito S; Kurosawa K; Yamaguchi K; Sugiura Y; Takizaki H; Yamashita Y; Katakura R; Sato I; Kawai M; Okada Y; Watanabe H; Kondoh G; Matsumoto S; Kishimoto A; Obata M; Matsumoto M; Fukuhara T; Motohashi H; Suematsu M; Komatsu M; Nakayama KI; Watanabe T; Soga T; Shima H; Maemondo M; Tanuma N
Cancer Cell; 2018 Mar; 33(3):355-367.e7. PubMed ID: 29533781
[TBL] [Abstract][Full Text] [Related]
17. PKM2 promotes reductive glutamine metabolism.
Liu M; Wang Y; Ruan Y; Bai C; Qiu L; Cui Y; Ying G; Li B
Cancer Biol Med; 2018 Nov; 15(4):389-399. PubMed ID: 30891326
[TBL] [Abstract][Full Text] [Related]
18. Base editing-mediated perturbation of endogenous PKM1/2 splicing facilitates isoform-specific functional analysis in vitro and in vivo.
Lin J; Wu S; Shen Q; Liu J; Huang S; Peng G; Qiao Y
Cell Prolif; 2021 Aug; 54(8):e13096. PubMed ID: 34240779
[TBL] [Abstract][Full Text] [Related]
19. The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissues.
Li L; Cheng S; Yeh Y; Shi Y; Henderson N; Price D; Gu X; Yu X
Front Oncol; 2024; 14():1392085. PubMed ID: 38680860
[TBL] [Abstract][Full Text] [Related]
20. No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis.
Bluemlein K; Grüning NM; Feichtinger RG; Lehrach H; Kofler B; Ralser M
Oncotarget; 2011 May; 2(5):393-400. PubMed ID: 21789790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
